Navigation Links
Consultancy agreement with Scorpion Performance Inc.

RENO, Nev., March 6, 2013 /PRNewswire/ -- Global Equity International Inc. (OTCQB Ticker: GEQU), a specialist consultancy firm based in Dubai and London has signed new consultancy contract with Scorpion Performance Inc., a Florida based corporation, bringing in a new long term client to the Company.  The contract states that Global Equity Partners Plc., a fully owned subsidiary and the operational arm of GEQU, will consult with Scorpion Performance Inc. to assist the company with a full IPO on the Dubai NASDAQ. Our agreed fees will be cash and equity based.

Scorpion Performance Inc. is a precision manufacturer with two distinct divisions.

  • Scorpion Racing Products is the marketing and distribution company for the automotive products that Scorpion Performance manufactures. Scorpion Racing Products' online ecommerce web site allows customers to buy direct.
  • Scorpion Medical, Inc. manufactures precision medical instruments and implants for the medical device industry. The company uses its latest technology equipment to produce the highest quality products with substantial speed and cost efficiency.

We at Global Equity International Inc. (GEQU) see Scorpion Performance Inc. being one of the market leaders in the U.A.E. for their medical products in particular and view the equity in Scorpion to be a tremendous long term asset for our Company and our shareholders. Peter Smith , CEO of Global Equity International Inc., commented: 'We have been talking to Scorpion Performance for many months now and we are delighted to be able to finally put pen to paper, Scorpion have a strong, innovative product range, great management and high ambition. We believe Scorpion will grow to become a market leader in its field in particular with its FDA approved medical technology."


This press release may include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements related to anticipated revenues, expenses, earnings, operating cash flows, the outlook for markets and the demand for products. Forward-looking statements are not guarantees of future performance and are inherently subject to uncertainties and other factors which could cause actual results to differ materially from the forward-looking statements. Such statements are based upon, among other things, assumptions made by, and information currently available to, management, including management's own knowledge and assessment of the Company's industry and competition. The Company refers interested persons to its most recent Annual Report on Form 10-K and its other SEC filings for a description of additional uncertainties and factors, which may affect forward-looking statements. The Company assumes no duty to update its forward-looking statements.


Enzo Taddei – CFO & Director
Tel + 321 200 0142

SOURCE Global Equity International Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Cylene Pharmaceuticals and TetraGene Enter Agreement for Quarfloxin and Anticancer Quadruplex Technologies
2. DMH International Announces Agreement with MyDICOM and ChangZhou Wealth Information & Technology Co. Ltd
3. Breg Signs Agreement with HealthTrust
4. DMH International Completes Agreement With Wake Forest University
5. Ventana and Biocare Medical sign p63 license agreement to aid in the differential diagnosis of benign and malignant prostate lesions
6. Medical Sales College Signs Training Agreement With TASSMA, Inc.
7. Simbionix Signs an Agreement with the Laparoscopic Surgical Skills Foundation (LSS)
8. Swiss Companies Debiotech and Valtronic Announce Partnership Agreement on the JewelPUMP for Diabetic Patients
9. Selexis Announces Expansion of R&D License Agreement with Amgen
10. ProGaming Platforms Corp. Executes Share Swap Agreement With BioMedix Ltd.
11. QIAGEN Enters Into Broad Collaboration Agreement With Lilly for the Development and Commercialization of Companion Diagnostics
Post Your Comments:
(Date:11/25/2015)... DUBLIN , Nov. 25, 2015 /PRNewswire/ ... announced the addition of the "Global ... to their offering. --> ... "Global Brain Monitoring Devices Market 2015-2019" ... Research and Markets ( ) ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... , Nov. 25, 2015  Linden Care, LLC, a ... treatment outcomes for patients suffering from chronic pain, said ... a Temporary Restraining Order (TRO) enjoining Express Scripts from ... companies. --> --> ... of its legal options. --> ...
Breaking Medicine Technology:
(Date:11/26/2015)... (PRWEB) , ... November 26, 2015 , ... Inevitably when ... Many customers choose to buy during the Black Friday and Cyber Monday ... don’t need to search the Internet high and low to find the best massage ...
(Date:11/26/2015)... ... November 26, 2015 , ... Somu Sivaramakrishnan announced ... franchise owner, Somu now offers travelers, value and care based Travel Services, including ... sales, as well as, cabin upgrades and special amenities such as, shore excursions, ...
(Date:11/26/2015)... ... November 26, 2015 , ... Jobs in hospital medical ... professionals and offered by healthcare staffing agency Aureus Medical Group . ... of October 2015 among those searching for healthcare jobs through the company’s website, ...
(Date:11/26/2015)... ... November 26, 2015 , ... WorldCare International, Inc., ... the 61st annual Employee Benefits Conference. The Employee Benefits Conference was hosted by ... through Wednesday, November 11th, 2015. The conference was held at the Hawaii Convention ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... consultation, has collaborated with Women’s Web – an online resource for Indian ... on mental and emotional well-being relationship, life balance, stress, professional development, and ...
Breaking Medicine News(10 mins):